These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27611369)

  • 1. Clinical benefits of natriuretic peptides and galectin-3 are maintained in old dyspnoeic patients.
    Teixeira A; Arrigo M; Vergaro G; Cohen-Solal A; Mebazaa A
    Arch Gerontol Geriatr; 2017; 68():33-38. PubMed ID: 27611369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.
    Mueller T; Gegenhuber A; Leitner I; Poelz W; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2016 Dec; 463():158-164. PubMed ID: 27983996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.
    Behnes M; Bertsch T; Weiss C; Ahmad-Nejad P; Akin I; Fastner C; El-Battrawy I; Lang S; Neumaier M; Borggrefe M; Hoffmann U
    Int J Cardiol; 2016 Jan; 203():398-406. PubMed ID: 26539964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
    J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure.
    Seronde MF; Gayat E; Logeart D; Lassus J; Laribi S; Boukef R; Sibellas F; Launay JM; Manivet P; Sadoune M; Nouira S; Solal AC; Mebazaa A;
    Int J Cardiol; 2013 Oct; 168(4):3404-11. PubMed ID: 23684562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute cardiac dyspnea in the emergency department: diagnostic value of N-terminal prohormone of brain natriuretic peptide and galectin-3.
    Stoica A; Şorodoc V; Lionte C; Jaba IM; Costache I; Anisie E; Tuchiluș C; Rusalim Petriș O; Sîrbu O; Jaba E; Ceasovschih A; Vâţă L; Şorodoc L
    J Int Med Res; 2019 Jan; 47(1):159-172. PubMed ID: 30222016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.
    van Kimmenade RR; Januzzi JL; Ellinor PT; Sharma UC; Bakker JA; Low AF; Martinez A; Crijns HJ; MacRae CA; Menheere PP; Pinto YM
    J Am Coll Cardiol; 2006 Sep; 48(6):1217-24. PubMed ID: 16979009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term mortality risk in emergency department acute heart failure.
    Peacock WF; Nowak R; Christenson R; DiSomma S; Neath SX; Hartmann O; Mueller C; Ponikowski P; Möckel M; Hogan C; Wu AH; Richards M; Filippatos GS; Anand I; Ng LL; Daniels LB; Morgenthaler N; Anker SD; Maisel AS
    Acad Emerg Med; 2011 Sep; 18(9):947-58. PubMed ID: 21906204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3, a prognostic marker--and a therapeutic target?
    Pereira AR; Menezes Falcão L
    Rev Port Cardiol; 2015 Mar; 34(3):201-8. PubMed ID: 25746675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
    Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GALA study: relationship between galectin-3 serum levels and short- and long-term outcomes of patients with acute heart failure.
    Miró Ò; González de la Presa B; Herrero-Puente P; Fernández Bonifacio R; Möckel M; Mueller C; Casals G; Sandalinas S; Llorens P; Martín-Sánchez FJ; Jacob J; Bedini JL; Gil V
    Biomarkers; 2017 Dec; 22(8):731-739. PubMed ID: 28406038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute heart failure in elderly patients admitted to the emergency department with acute dyspnea: a multimarker approach diagnostic study.
    Taheri O; Mauny F; Ray P; Puyraveau M; Dubart AE; Chenevier-Gobeaux C; Seronde MF; Mebazaa A; Martin B; Pretalli JB; Desmettre T;
    Eur J Emerg Med; 2023 Oct; 30(5):347-355. PubMed ID: 37598373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I.
    Hoffmann U; Espeter F; Weiß C; Ahmad-Nejad P; Lang S; Brueckmann M; Akin I; Neumaier M; Borggrefe M; Behnes M
    BMC Cardiovasc Disord; 2015 Jun; 15():50. PubMed ID: 26072112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.
    Ray P; Delerme S; Jourdain P; Chenevier-Gobeaux C
    QJM; 2008 Nov; 101(11):831-43. PubMed ID: 18664534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
    El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure).
    Richards M; Di Somma S; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Clopton P; Filippatos GS; Anand I; Ng L; Daniels LB; Neath SX; Shah K; Christenson R; Hartmann O; Anker SD; Maisel A
    JACC Heart Fail; 2013 Jun; 1(3):192-9. PubMed ID: 24621869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of natriuretic peptides for acute heart failure: a review.
    Zhou SL; Zhang J; Song TT; Li X; Wang HX
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2415-2420. PubMed ID: 29762843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptides, nitrite/nitrate and superoxide dismutase have additional value on top of the GRACE score in prediction of one-year mortality and rehospitalisation for heart failure in STEMI patients - Multiple biomarkers prospective cohort study.
    Parenica J; Kala P; Pavkova MG; Tomandl J; Spinar J; Littnerova S; Jarkovsky J; Mebazaa A; Tomandlova M; Dastych M; Gottwaldova J; Gayat E
    Int J Cardiol; 2016 May; 211():96-104. PubMed ID: 26991556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.